Social Media Ideas for Avita Medical

AVITA Medical, Inc. (RCEL) Q2 2026 Earnings Call Transcript

Aviva Aesthetics Expands Into Ohio Through Partnership With Vitality Health

Eighth partnership of 2026 brings the entrepreneur-owned alternative to private equity to Northeast Ohio CHICAGO, July 21, 2026 /PRNewswire-PRWeb/ -- Aviva Aesthetics, the nation's...

Sona Dermatology Introduces Ageless AI: Visualize Your Results Before Treatment with Cutting-Edge Technology

SЕЌna Dermatology enhances the cosmetic experience with Ageless AI, allowing patients to visualize their potential results before undergoing laser skin resurfacing and other aesthe...

Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill

Set to go public via a reverse merger, Avere has licensed from a prolific Chinese drugmaker rights to a potential threat to medicines like Skyrizi and Icotyde. 

Philips launches ReAura, a new LED skincare mask and beauty ritual for younger-looking skin1

• A unique and flexible 3-in-1 design lets you tailor each session to your needs, giving you the option to treat your full face, or target the eye area and neck individually - -...

Aesthetics Hawaii Launches Physician-Guided Hyperbaric Oxygen Therapy in Honolulu, Bringing Hospital-Grade Chamber Techn...

Under the direction of Dr. David Yew, MD, the Honolulu practice introduces State of the Art Hard-Shell, 2.0 ATA hyperbaric chamber therapy under Direct Physician Oversight HONOLULU...

Skin Artistry Clinic Alamo Expands Longevity Medicine and Wellness Program to Walnut Creek for Everyday Patients

Dr. Malda Al Daoudi

Rejuran: Advancing Regenerative Aesthetics Through Skin Healing and Rejuvenation As regenerative medicine continues to shape the future of aesthetic dermatology, treatments that st...

FDA Approves RHA Redensity Eye for Infraorbital Volume Deficiencies

FDA approves RHA Redensity Eye for correction of moderate to severe tissue volume deficiencies in the infraorbital region in adults ages 22 and older.

Dr. Maryam Zamani Becomes First Plastic Surgeon on the West Coast to Perform Comprehensive Fat Transfer Procedure Using...

Dual board-certified plastic surgeon advances regenerative body contouring by integrating ultrasound-assisted liposuction, Renuvion® skin-tightening technology, and closed-loop fa...

R1 acquiring Humata Health to bolster AI-powered prior authorizations

Humata’s AI-powered solution has allowed physicians to achieve a 96% first-pass approval rate while reducing write-offs by 30%, executives say.

FACTOR X Emerges from Stealth with Novel RNA - based Technology to Transform the Global Beauty Industry

FACTOR X is a newly launched longevity-focused beauty technology company developing a breakthrough cellular delivery platform designed to transform the anti-aging skincare industry...

FDA green lights Priovant drug for rare skin disease

Lisraya’s clearance marks the first approval of a drug the Roivant subsidiary licensed from Pfizer and has since positioned against multiple rare inflammatory conditions.

Attovia files for IPO to take on Sanofi and Regeneron’s Dupixent

Attovia Therapeutics has filed for an IPO to secure funding for assets, including a potential challenger to Sanofi and Regeneron’s Dupixent and Galderma’s Nemluvio.

Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results

Mipletamig Drives Clinical Momentum with Strong Frontline AML Data, Path Toward Phase 2Chief Scientific Officer Appointment Strengthens Execution Across Advancing Oncology Pipeline...

PermeaDerm Study Shows Lower Costs, Comparable Wound Healing vs Allograft

PermeaDerm reduced product cost by 70% and preparation time by 95.7% compared with cadaveric allograft while achieving comparable clinical outcomes in a randomized study.

Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment

- A new chapter in skincare has arrived -- This will be Dermata's first commercial product launch, planned for August 25, 2026 -- Join the waitlist at tomeskincare.com -

‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit

Early indicators from a compassionate use plan led analysts to hike projections for daraxonrasib. Elsewhere, Intellia believes it’s answered a key safety question and Arrowhead mov...

Res-Q Unveils New 'Beauty Omega' Formula, Expanding Beyond Omega-3s to Meet Rising Consumer Demand for Nutricosmetics

As consumers increasingly embrace beauty-from-within nutrition, Res-Q introduces a highly concentrated Omega-7 formula designed to support skin moisture and elasticity, nourish the...

Lumina Care Launches Redesigned Website Reflecting National Growth Across Post-Acute and Skilled Nursing

The redesigned luminacare.com gives healthcare organizations detailed guidance on every clinical program and introduces Lumina360, alongside the full suite of clinical programs off...

Core Age Rx Launches Comprehensive “Skin & Appearance” Line to Deliver Prescription-Strength, Dermatologist-Guided S...

Attovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO

Attovia Therapeutics has accreted a hefty $289 million from its IPO to power its anti-itch drugs through clinical development, marking another upsized listing in what has become a...

DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)

Launch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store

AbbVie-backed ADARx plans IPO to bankroll array of clinical-stage siRNA therapies

ADARx has reinvigorated its ambitions to go public as the AbbVie-backed biotech looks to fund ongoing clinical trials of a range of next-gen small interfering RNA medicines.